Prostate Cancer Reports
54

Volume 5 Supplement 3
March 2017



Home > Prostate Cancer Reports > Volume 5, Year 2017 > Supplement 3, March


CONTENTS



DIAGNOSIS AND EVALUATION
PROGNOSIS AND OUTCOMES
TREATMENT





DIAGNOSIS AND EVALUATION



Schulz RJ.
The Diagnosis of Prostate Cancer.
J Appl Clin Med Phys. 2016 Nov;17(6):457-458. doi: 10.1120/jacmp.v17i6.6676.
Source | Abstract | Full text | Similar articles





PROGNOSIS AND OUTCOMES



Lee S, Kim KB, Jo JK, Ho JN, Oh JJ, Jeong SJ, Hong SK, Byun SS, Choe G, Lee SE.
Prognostic Value of Focal Positive Surgical Margins After Radical Prostatectomy.
Clin Genitourin Cancer. 2016 Aug;14(4):e313-9. doi: 10.1016/j.clgc.2015.12.013. Epub 2015 Dec 29.
Source | Abstract | Full text | Similar articles





TREATMENT



Buscariollo DL, Drumm M, Niemierko A, Clayman RH, Galland-Girodet S, Rodin D, Feldman AS, M Dahl D, McGovern FJ, F Olumi A, Eidelman A, Shipley WU, Zietman AL, Efstathiou JA.
Long-term results of adjuvant versus early salvage postprostatectomy radiation: A large single-institutional experience.
Pract Radiat Oncol. 2017 Mar - Apr;7(2):e125-e133. doi: 10.1016/j.prro.2016.10.010. Epub 2016 Oct 19.
Source | Abstract | Full text | Similar articles




Falchook AD, Basak R, Mohiuddin JJ, Chen RC.
Evaluation of the effectiveness of adding androgen deprivation to modern dose-escalated radiotherapy for men with favorable intermediate-risk prostate cancer.
Cancer. 2016 Aug 1;122(15):2341-9. doi: 10.1002/cncr.30049. Epub 2016 May 18.
Source | Abstract | Full text | Similar articles




Falchook AD, Basak R, Mohiuddin JJ, Chen RC.
Use of Androgen Deprivation Therapy With Radiotherapy for Intermediate- and High-Risk Prostate Cancer Across the United States.
JAMA Oncol. 2016 Sep 1;2(9):1236-8. doi: 10.1001/jamaoncol.2016.1143.
Source | Abstract | Full text | Similar articles




Klotz L.
Active surveillance for low-risk prostate cancer.
Curr Urol Rep. 2015 Apr;16(4):24. doi: 10.1007/s11934-015-0492-z. Epub 2015 March 13.
Source | Abstract | Full text | Similar articles




Nguyen PL, Aizer A, Assimos DG, D'Amico AV, Frank SJ, Gottschalk AR, Gustafson GS, Hsu IC, McLaughlin PW, Merrick G, Rosenthal SA, Showalter TN, Taira AV, Vapiwala N, Yamada Y, Davis BJ; American College of Radiology, Expert Panel on Radiation OncologyProstate.
ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer.
Am J Clin Oncol. 2014 Jun;37(3):278-88. doi: 10.1097/COC.0000000000000049.
Source | Abstract | Full text | Similar articles




Zumsteg ZS, Spratt DE, Pei X, Yamada Y, Kalikstein A, Kuk D, Zhang Z, Zelefsky MJ.
Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy.
Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1012-7. doi: 10.1016/j.ijrobp.2012.07.2374. Epub 2012 Sep 14.
Source | Abstract | Full text | Similar articles